GIVE MISS CALL ON :- +91 99774 99927

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 12 APR 2019

market-wrap-up

Closing Bell: Sensex ends 160 pts higher, Nifty around 11,650; ITC gains 3%.

The benchmark indices ended higher on Friday with Nifty ended above 11,600 level.
At close, the Sensex was up 160.10 points at 38767.11, while Nifty was up 46.80 points at 11,643.50. About 1355 shares have advanced, 1138 shares declined, and 153 shares are unchanged.
Shares of IT major, Tata Consultancy Services (TCS) and Infosys ended flat ahead of their March quarter earnings to be released later today.
GAIL, ITC, Maruti Suzuki, Cipla and Zee Entertainment were among major top gainers on the Nifty, while losers were Indiabulls Housing Finance, IOC, Bajaj Finance, L&T and Tata Motors.
Among the sectors, auto and FMCG indices led the gainers with 1 percent gain followed by IT, pharma and bank.

HEADLINES OF THE DAY
Central Electricity Regulatory Commission (CERC) approved higher tariff for Adani Power 2000 MW Mundra plant, reported CNBC-TV18.
Max Group enters commercial real estate: Max Estates, a subsidiary of Max Ventures & Industries announced the opening of its flagship office project Max Towers located on the Delhi Noida Directway (DND).
RITES order book up by 27.5% during FY19: RITES order book has substantially improved from Rs 4818 crore as on 31St March 2018 to Rs.6142 crore at the end of the FY19 (accounts for the FY19 are under audit). Company has secured more than 300 projects/contracts including extension in scope of projects during FY19.
Motherson Sumi Systems slips after HSBC cuts price target :- Motherson Sumi Systems shares fell over a percent intraday after British investment firm HSBC maintained its buy call on the stock but slashed price target to Rs 170 from Rs 233 per share.
Q4 for Auto may be Challenging :- Q4FY19 for auto sector is expected to be a challenging quarter, with volumes declining across segments, HDFC Securities said.
Lupin shares gained 2 percent after it announced the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), having received an approval from the United States Food and Drug Administration (FDA).

The crucial resistance for Nifty spot is now seen at 10720 and above this 10920 Support for the immediate term is now placed at 10480 next support will be 10370.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

Leave a Reply

Checking...

Ouch! There was a server error.
Retry »

Sending message...

FREE TRIAL REQUEST


CapitalStars FORUM